The Science of Listening
By Fabrice Chouraqui
June 15, 2026
Why patient voices must shape rare disease innovation
4 min read
False
Advertisement
Development & Clinical
The Scalability Challenge in MSC Therapies
June 12, 2026
John Yoshi Shyu on why mesenchymal stem cell programs stall – and how early manufacturing decisions can determine clinical and commercial success
4 min read
Roving Reporter Asks: What Emerging Approaches Could Define the Next Wave of Advanced Therapies?
June 11, 2026
IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore the emerging modalities and technologies that could shape the next era of cell and gene therapy
Earendil: A Blueprint for a Multipolar Life Sciences Era
By Joe Renny
June 5, 2026
The $787M financing points to a new global architecture in biotech
5 min read
HTC-19 Profile: What’s Cooking in the mRNA Lab?
June 3, 2026
Jonathan Maurer of the University of Geneva discusses his work with Sanofi and Waters – and why good analytical science has a lot in common with good cooking
3 min read
The Case for Simulating Pregnancy
By Jessica Allerton
June 2, 2026
Why drug trials exclude pregnant women – and how simulation could change that
7 min read
Reimagining Risk and Resilience
By Stephanie Harden, Tracy Hibbs
May 29, 2026
Accelerating analytical data management for the next-generation laboratory
7 min read
When Insight Meets Urgency in Cell and Gene Therapy
By Ruizhi Wang, Alan J. Dickson
May 27, 2026
Balancing deep biological insight with the realities of development is now central to progress in advanced medicine
6 min read
Infrastructure at Scale: A Conversation with Germfree’s New CEO
May 26, 2026
We speak with Carol Houts about advanced therapy manufacturing, modular cleanrooms, and the challenge of scaling GMP infrastructure
7 min read
Analytical Champions: Tao Chen
May 22, 2026
A new series championing analytical scientists in pharma begins with Genentech’s rising star
7 min read
